Entera reports comparable results for single-tablet EB613 versus injection
Go back to Entera reports comparable results for single-tablet EB613 versus injection| Entrx Corporation (NASDAQ: ENTX) | Delayed: 2.91 -0.04 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.95 | 52 Week High | $0.30 | |||
| Open | $2.94 | 52 Week Low | $0.10 | |||
| Day High | $3.09 | P/E | N/A | |||
| Day Low | $2.80 | EPS | $0.00 | |||
| Volume | 130,631 | |||||
